Oncomatryx is a biopharmaceutical company focused on the tumor microenvironment.
Oncomatryx has raised $26.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2025.
Oncomatryx's investors include Centre for the Development of Industrial Technology (CDTI), Gestion De Capital Riesgo Del Pais Vasco.
Oncomatryx is headquartered in Derio, Spain.
Oncomatryx is a biopharmaceutical company focused on the tumor microenvironment.
Oncomatryx is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oncomatryx — Funding & Investors." VCBacked, January 27, 2025, https://www.vcbacked.co/company/oncomatryx. Accessed August 14, 2026.
VCBacked. (2025). Oncomatryx — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/oncomatryx
{{cite web |title=Oncomatryx — Funding & Investors |url=https://www.vcbacked.co/company/oncomatryx |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated